Year None2024202320222021202020192018201720162015 Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 4, 2024 at 4:01 PM EDT Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update August 13, 2024 at 4:02 PM EDT Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) July 10, 2024 at 4:01 PM EDT Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) June 7, 2024 at 5:59 PM EDT Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference May 29, 2024 at 4:01 PM EDT Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update May 9, 2024 at 4:01 PM EDT Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 6, 2024 at 4:05 PM EDT Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) April 8, 2024 at 4:01 PM EDT Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update March 14, 2024 at 4:01 PM EDT Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) March 8, 2024 at 4:05 PM EST Pagination Current page 1 Page 2 Next page next › Last page last »
Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 4, 2024 at 4:01 PM EDT
Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update August 13, 2024 at 4:02 PM EDT
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference May 29, 2024 at 4:01 PM EDT
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update May 9, 2024 at 4:01 PM EDT
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update March 14, 2024 at 4:01 PM EDT